Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.276 SEK | -4.00% |
|
-8.21% | -97.26% |
05-22 | Xbrane Successfully Scale Up Xdivane- Biosimilar Candidate to Opdivo®? | CI |
05-16 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 |
Chart calendar Xbrane Biopharma AB
Upcoming events on Xbrane Biopharma AB
Past events on Xbrane Biopharma AB
2024-05-16 03:00 | Q1 2024 Earnings Call |
2024-05-16 02:00 | Q1 2024 Earnings Release |
2024-05-02 10:30 | Annual General Meeting |
2024-03-20 06:50 | Redeye Theme: Commercialization in Life Science |
2024-02-26 07:00 | Q4 2023 Earnings Call |
2024-02-26 02:00 | Q4 2023 Earnings Release |
2024-02-22 10:30 | Extraordinary Shareholders Meeting |
2023-11-30 17:00 | Q3 2023 Earnings Call |
2023-08-29 03:00 | Q2 2023 Earnings Call |
2023-08-29 02:00 | Q2 2023 Earnings Release |
2023-05-31 05:00 | Q1 2023 Earnings Call |
2023-05-31 02:00 | Q1 2023 Earnings Release |
2023-05-31 00:00 | ABGSC Life Science Summit |
2023-05-03 | Annual General Meeting |
2023-03-15 | BioStock Investor Meeting |
2023-02-17 04:00 | FY 2022 Earnings Call |
2023-02-17 02:00 | FY 2022 Earnings Release |
2022-11-26 | Redeye Life Science Day_Interview |
2022-10-28 08:00 | Q3 2022 Earnings Call |
2022-10-28 02:00 | Q3 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 6,60 - | 15,6 18,7 -16.88% | 57,6 65,0 -11.32% | 239 220 8.5% | 344 |
EBITDA Million SEK | Released Forecast Spread | -140 -113 -24.32% | -219 -198 -10.45% | -168 -224 24.84% | -150 -142 -5.38% | -288 -300 3.86% | -166 |
EBIT Million SEK | Released Forecast Spread | -165 -113 -45.68% | -225 -200 -12.57% | -181 -224 19.55% | -166 -152 -9.35% | -322 -316 -2.05% | -183 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -166 -113 -46.94% | -226 -201 -12.71% | -183 -225 18.6% | -169 -150 -12.56% | -322 -335 3.85% | -186 |
Net income Million SEK | Released Forecast Spread | -166 -83,0 -100.04% | -226 -201 -12.71% | -188 -225 16.32% | -173 -148 -16.69% | -388 -336 -15.57% | -186 |
EPS SEK | Released Forecast Spread | -14,8 -5,40 -174.81% | -12,5 -10,9 -15.02% | -7,77 -9,83 20.92% | -6,75 -5,62 -20.19% | -13,5 -11,7 -15.88% | -0,13 |
Announcement Date | 28/02/20 | 26/02/21 | 24/02/22 | 17/02/23 | 26/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 7,19 5,00 43.8% | 15,6 5,00 212.62% | 13,9 49,0 -71.56% | 17,3 9,19 88.41% | 61,8 12,0 415.24% | 51,1 64,4 -20.68% | 58,9 52,6 12.06% | 66,9 50,6 32.3% | 14,1 57,7 -75.64% | 110 | 75,0 | 90,1 |
EBITDA Million SEK | Released Forecast Spread | -32,9 -66,0 50.15% | -28,4 -81,0 64.98% | -37,6 -37,0 -1.72% | -50,7 | -81,6 -81,5 -0.12% | -69,2 -85,5 19.01% | -76,0 -61,0 -24.65% | -18,5 | -49,5 | -46,5 | ||
EBIT Million SEK | Released Forecast Spread | -36,8 -66,0 44.27% | -32,4 -81,0 60% | -42,0 -37,0 -13.49% | -55,0 | -88,6 -48,1 -84.15% | -89,7 -85,2 -5.24% | -86,5 -89,3 3.15% | -85,1 -65,7 -29.66% | -22,3 | -54,0 | -50,9 | |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -37,5 -66,0 43.16% | -33,1 -81,0 59.19% | -42,6 -37,0 -15.17% | -55,3 -36,5 -51.48% | -57,9 -35,0 -65.53% | -90,6 -48,8 -85.69% | -80,9 -89,5 9.53% | -92,6 -96,7 4.18% | -97,1 -70,2 -38.33% | -67,6 | -67,0 | -66,7 |
Net income Million SEK | Released Forecast Spread | -36,1 -66,0 45.27% | -33,8 -81,0 58.3% | -41,9 -37,0 -13.2% | -60,7 -36,1 -68.41% | -58,4 -34,5 -69.32% | -91,0 -48,8 -86.57% | -81,2 -89,5 9.21% | -158 -96,7 -62.94% | -97,4 -70,2 -38.75% | -67,6 | -67,0 | -66,7 |
EPS SEK | Released Forecast Spread | -1,44 -2,64 45.53% | -1,35 -3,25 58.41% | -1,67 -1,29 -29.43% | -2,25 -1,37 -64.25% | -2,12 -1,25 -69.08% | -3,22 -1,77 -81.56% | -2,78 -3,06 9.22% | -5,28 -3,31 -59.55% | -0,30 -0,05 -566.67% | -0,02 | -0,02 | -0,02 |
Announcement Date | 05/05/22 | 22/07/22 | 28/10/22 | 17/02/23 | 31/05/23 | 29/08/23 | 30/11/23 | 26/02/24 | 16/05/24 | - | - | - |
2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Xbrane Biopharma AB
2024-06-07 02:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 16:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 16:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- XBRANE Stock
- Calendar Xbrane Biopharma AB